Found: 7
Select item for more details and to access through your institution.
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 717, doi. 10.3390/vaccines10050717
- By:
- Publication type:
- Article
Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 239, doi. 10.3390/vaccines9030239
- By:
- Publication type:
- Article
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44265-0
- By:
- Publication type:
- Article
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dosedependent protection against SARS-CoV-2 replication and disease in hamsters.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1138629
- By:
- Publication type:
- Article
Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220986
- By:
- Publication type:
- Article
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 632, p. 1, doi. 10.1126/scitranslmed.abi5735
- By:
- Publication type:
- Article
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 6, p. 1, doi. 10.1371/journal.ppat.1010574
- By:
- Publication type:
- Article